300 related articles for article (PubMed ID: 27142035)
1. [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].
Heiligenhaus A; Tappeiner C; Walscheid K; Heinz C
Ophthalmologe; 2016 May; 113(5):391-7. PubMed ID: 27142035
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
Pleyer U; Pohlmann D; Stübiger N
Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
[TBL] [Abstract][Full Text] [Related]
3. [Immunomodulation and neuroprotection in optic neuritis].
Beisse F; Diem R
Ophthalmologe; 2016 May; 113(5):398-401. PubMed ID: 27165274
[TBL] [Abstract][Full Text] [Related]
4. TNF inhibition for ophthalmic indications: current status and outlook.
Rifkin LM; Birnbaum AD; Goldstein DA
BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
[TBL] [Abstract][Full Text] [Related]
6. [Uveitis in juvenile idiopathic arthritis].
Foeldvari I; Walscheid K; Heiligenhaus A
Z Rheumatol; 2017 Oct; 76(8):664-672. PubMed ID: 28812127
[TBL] [Abstract][Full Text] [Related]
7. Current therapeutic approaches to autoimmune chronic uveitis in children.
Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
[TBL] [Abstract][Full Text] [Related]
8. Uveitis in juvenile idiopathic arthritis.
Heiligenhaus A; Minden K; Föll D; Pleyer U
Dtsch Arztebl Int; 2015 Feb; 112(6):92-100, i. PubMed ID: 25721436
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
[TBL] [Abstract][Full Text] [Related]
10. Uveitis in juvenile idiopathic arthritis: recent therapeutic advances.
Wells JM; Smith JR
Ophthalmic Res; 2015; 54(3):124-7. PubMed ID: 26315291
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and therapy of uveitis in childhood].
Kiss J; Gaál V; Nyul Z; Mosdósi B
Orv Hetil; 2019 Aug; 160(34):1335-1339. PubMed ID: 31423830
[TBL] [Abstract][Full Text] [Related]
12. Cutting-edge issues in autoimmune uveitis.
Levy RA; de Andrade FA; Foeldvari I
Clin Rev Allergy Immunol; 2011 Oct; 41(2):214-23. PubMed ID: 21913066
[TBL] [Abstract][Full Text] [Related]
13. [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)].
Horneff G
Z Rheumatol; 2005 Jun; 64(5):317-26. PubMed ID: 15965816
[TBL] [Abstract][Full Text] [Related]
14. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
Arthritis Care Res (Hoboken); 2019 Jun; 71(6):703-716. PubMed ID: 31021540
[TBL] [Abstract][Full Text] [Related]
15. [TNFalpha inhibitors in the treatment of uveitis].
Greiner K; Plskova J
Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
Miserocchi E; Modorati G; Berchicci L; Pontikaki I; Meroni P; Gerloni V
Br J Ophthalmol; 2016 Jun; 100(6):782-6. PubMed ID: 26396026
[TBL] [Abstract][Full Text] [Related]
17. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
[TBL] [Abstract][Full Text] [Related]
18. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
Arthritis Rheumatol; 2019 Jun; 71(6):864-877. PubMed ID: 31021511
[TBL] [Abstract][Full Text] [Related]
19. Biologic agents in experimental autoimmune uveitis.
Giuliari GP; Sadaka A; Hinkle DM
Int Ophthalmol; 2014 Feb; 34(1):145-56. PubMed ID: 23494482
[TBL] [Abstract][Full Text] [Related]
20. Pediatric rheumatology for the adult rheumatologist II: uveitis in juvenile idiopathic arthritis.
Wright T; Cron RQ
J Clin Rheumatol; 2007 Aug; 13(4):205-10. PubMed ID: 17762455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
